Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
31 studies found for:    Open Studies | "Graves Disease"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Comparative Study of Different I-131 Doses in Graves' Disease
Condition: Graves' Disease
Interventions: Drug: Low dose of I-131;   Drug: Intermediate dose;   Drug: High dose
2 Not yet recruiting Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Condition: Graves Disease
Intervention:
3 Recruiting Radioactive Iodide Therapy for Pediatric Graves' Disease
Condition: Graves' Disease
Interventions: Radiation: RAI treatment;   Drug: ATD Group
4 Recruiting Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
Conditions: Graves' Disease;   Thyroid Disease;   Hyperthyroidism
Intervention: Other: Decision Aid
5 Recruiting Early Levothyroxine Post Radioactive Iodine
Condition: Graves' Disease
Intervention: Drug: Levothyroxine
6 Recruiting Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism
Condition: Graves' Hyperthyroidism
Interventions: Dietary Supplement: Selenium;   Other: Placebo
7 Unknown  Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease
Condition: Graves' Disease
Intervention:
8 Recruiting Post-Radioiodine Graves' Management: The PRAGMA-Study
Condition: Graves' Disease
Intervention:
9 Recruiting Doxycycline Treatment in Mild Graves' Orbitopathy
Conditions: Graves Ophthalmopathy;   Graves Disease;   Eye Diseases;   Thyroid Diseases;   Endocrine System Diseases;   Eye Diseases, Hereditary;   Hyperthyroidism;   Autoimmune Diseases;   Immune System Diseases
Interventions: Drug: Doxycycline;   Drug: placebo
10 Recruiting Bupivacaine Injection of Eye Muscles to Treat Strabismus
Conditions: Strabismus;   Esotropia;   Exotropia;   Graves Disease;   Nystagmus
Intervention: Drug: Bupivacaine
11 Not yet recruiting Role of the Microbiome in Graves' Orbitopathy
Condition: Graves' Disease
Intervention: Biological: LAB4
12 Recruiting Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
Condition: Graves Disease (Basedow's Disease)
Interventions: Drug: the early prophylactic introduction of low dose of LT4 (50 µg/d) at 15 days post-ablation;   Drug: The initiation of LT4 as soon as the first biological signs of hypothyroidism.
13 Not yet recruiting B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Rituximab;   Drug: Placebo
14 Recruiting Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)
Condition: Graves' Ophthalmopathy
Interventions: Drug: Bimatoprost;   Drug: Eye drop solution
15 Not yet recruiting The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Conditions: Thyroid Eye Disease;   Ocular Hypertension;   Glaucoma
Interventions: Drug: Prostaglandin Analog;   Drug: Timolol
16 Recruiting The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions
Conditions: Hypothyroidism;   Exophthalmos
Intervention: Radiation: Iodine 131
17 Unknown  The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy
Condition: Graves' Ophthalmopathy
Interventions: Procedure: Total Thyroidectomy;   Drug: Propylthiouracil
18 Recruiting A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy
Condition: Graves' Ophthalmopathy
Intervention: Drug: methylprednisolone, prednisone
19 Recruiting Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People
Condition: Graves' Ophthalmopathy
Intervention:
20 Not yet recruiting Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
Condition: Thyroid Associated Ophthalmopathies
Intervention: Drug: bimatoprost 0.03%

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years